Literature DB >> 22095981

Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels--brief report.

Pei Zhang1, Angela Huang, Jacopo Ferruzzi, Robert P Mecham, Barry C Starcher, George Tellides, Jay D Humphrey, Frank J Giordano, Laura E Niklason, William C Sessa.   

Abstract

OBJECTIVE: The goal of this study was to determine whether antagonizing microRNA (miR)-29 enhances elastin (ELN) levels in cells and tissues lacking ELN. METHODS AND
RESULTS: miR-29 mimics reduced ELN levels in fibroblasts and smooth muscle cells, whereas miR-29 inhibition increased ELN levels. Antagonism of miR-29 also increased ELN levels in cells from patients haploinsufficient for ELN and in bioengineered human vessels.
CONCLUSION: miR-29 antagonism may promote increased ELN levels during conditions of ELN deficiencies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095981      PMCID: PMC3288647          DOI: 10.1161/ATVBAHA.111.238113

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Functional arteries grown in vitro.

Authors:  L E Niklason; J Gao; W M Abbott; K K Hirschi; S Houser; R Marini; R Langer
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

2.  Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells.

Authors:  Pei Zhang; Thomas D Manes; Jordan S Pober; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

3.  Mechanical properties and compositions of tissue engineered and native arteries.

Authors:  Shannon L M Dahl; Caroline Rhim; Ying C Song; Laura E Niklason
Journal:  Ann Biomed Eng       Date:  2007-01-06       Impact factor: 3.934

4.  Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome.

Authors:  Zsolt Urbán; Sheila Riazi; Thomas L Seidl; Jodi Katahira; Leslie B Smoot; David Chitayat; Charles D Boyd; Aleksander Hinek
Journal:  Am J Hum Genet       Date:  2002-05-06       Impact factor: 11.025

Review 5.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

6.  Methods in elastic tissue biology: elastin isolation and purification.

Authors:  Robert P Mecham
Journal:  Methods       Date:  2008-05       Impact factor: 3.608

7.  Developmental regulation of elastin production. Expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels.

Authors:  M H Swee; W C Parks; R A Pierce
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

8.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.

Authors:  Eva van Rooij; Lillian B Sutherland; Jeffrey E Thatcher; J Michael DiMaio; R Haris Naseem; William S Marshall; Joseph A Hill; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

Review 9.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

Review 10.  Elastic fibres.

Authors:  Cay M Kielty; Michael J Sherratt; C Adrian Shuttleworth
Journal:  J Cell Sci       Date:  2002-07-15       Impact factor: 5.285

View more
  47 in total

1.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

2.  Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 days.

Authors:  Liqiong Gui; Michael J Boyle; Yishai M Kamin; Angela H Huang; Barry C Starcher; Cheryl A Miller; Michael J Vishnevetsky; Laura E Niklason
Journal:  Tissue Eng Part A       Date:  2014-02-06       Impact factor: 3.845

3.  MicroRNAs and Cardiovascular Disease.

Authors:  Carlos Fernández-Hernando; Angel Baldán
Journal:  Curr Genet Med Rep       Date:  2013-03

4.  Gradual loading ameliorates maladaptation in computational simulations of vein graft growth and remodelling.

Authors:  Abhay B Ramachandra; Jay D Humphrey; Alison L Marsden
Journal:  J R Soc Interface       Date:  2017-05       Impact factor: 4.118

5.  Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.

Authors:  Tsai-Der Chuang; Omid Khorram
Journal:  Fertil Steril       Date:  2019-12       Impact factor: 7.329

Review 6.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

7.  Restoring elastin with microRNA-29.

Authors:  Xiu Rong Dong; Mark W Majesky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

8.  Compromised mechanical homeostasis in arterial aging and associated cardiovascular consequences.

Authors:  J Ferruzzi; D Madziva; A W Caulk; G Tellides; J D Humphrey
Journal:  Biomech Model Mechanobiol       Date:  2018-05-12

9.  Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.

Authors:  Elisa Araldi; Aranzazu Chamorro-Jorganes; Coe van Solingen; C Fernández-Hernando; Y Suárez
Journal:  Curr Vasc Pharmacol       Date:  2013-05-13       Impact factor: 2.719

10.  Advances in biomimetic regeneration of elastic matrix structures.

Authors:  Balakrishnan Sivaraman; Chris A Bashur; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.